The average tumor volume of the CTNNB1 knockdown group was significantly smaller than those from the control group (Figure 4(a)), which showed that the tumor formation was suppressed in the cisplatin-treated group with CTNNB1 knockdown (Figure 4(b)). Here, CTNNB1 is linked to neoplasm.